0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Contempo Updates |

Recent Therapeutic Advances in Dermatology

Graeme M. Lipper, MD; Kenneth A. Arndt, MD; Jeffrey S. Dover, MD, FRCPC
JAMA. 2000;283(2):175-177. doi:10.1001/jama.283.2.175.
Text Size: A A A
Published online

Extract

Recent advances in dermatologic therapy include the use of imiquimod beyond its original use as a treatment for anogenital condylomata acuminata. Another immunomodulating drug, tacrolimus, has been used topically to treat a variety of dermatoses. New concepts in the management of toxic epidermal necrolysis will also be discussed.

Stanley MA.Mechanism of action of imiquimod. Papillomavirus Rep.1999;10:23-29.
Edwards L, Ferenczy A, Eron L.  et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol.1998;134:25-30.
Tyring SK, Arany I, Stanley MA.  et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis.1998;178:551-555.
Sidky YA, Borden EC, Weeks CE.  et al. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res.1992;52:3528-3533.
Syed T, Goswami J, Ahmadpour O.  et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol.1998;25:309-313.
Weeks CE, Gibson SJ.Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J Interferon Res Cytokine.1994;14:81-85.
Ruzicka T, Assmann T, Homey B.Tacrolimus: the drug for the turn of the millennium? Arch Dermatol.1999;135:574-580.
de Paulis A, Stellato C, Cirillo R.  et al. Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol.1992;99:723-727.
Reich K, Vente C, Neumann C.Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol.1998;139:755-757.
Ruzicka T, Bieber T, Schopf E.  et al. A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med.1997;337:816-821.
Zonneveld IM, Rubins A, Jablonska S.  et al. Topical tacrolimus is not effective in chronic plaque psoriasis. Arch Dermatol.1998;134:1101-1102.
Roujeau JC, Kelly J, Naldi L.  et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med.1995;333:1600-1607.
Rzany B, Correia O, Kelly JP.  et al. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case control study. Lancet.1999;353:2190-2194.
Kelemen J, Cioffi W, McManus W.  et al. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg.1995;180:273-278.
McGee T, Munster A.Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg.1998;102:1018-1022.
Halebian P, Madden M, Finklestein J.  et al. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann Surg.1986;204:503-512.
Egan C, Grant W, Morris S.  et al. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol.1999;40:458-461.
Chaidemenos G, Chrysomallis F, Sombolos K.  et al. Plasmapheresis in toxic epidermal necrolysis. Int J Dermatol.1997;36:218-221.
Heng MC, Allen SG.Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol.1991;25:778-786.
Viard I, Wehrli P, Bullani R.  et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science.1998;282:490-493.
Rzany B, Hering O, Mockenhaupt M.  et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol.1996;135:6-11.
Wolkenstein P, Adle H, Wechsler J.  et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol.1996;134:710-714.
Wolkenstein P, Latarjet J, Roujeau JC.  et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet.1998;352:1586-1589.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 13

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();